Wezlana Injection, Solution
Product Images NDC 84612-855

Product Visual Gallery

This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Wezlana (NDC 84612-855). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nuvaila Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Wezlana 01)

This text seems to describe the parts of a syringe used for injections or medical procedures. It includes components such as the plunger, plunger rod, body, needle, finger grip, label head guard clips, and needle cap. The image appears to illustrate how these parts are arranged within the syringe.*

FDA Label Image

Figure (Wezlana 02)

FDA Label Image

Figure (Wezlana 03)

FDA Label Image

Figure 1 (Wezlana 04)

FDA Label Image

Figure (Wezlana 05)

This text provides a list of various components of a medical syringe, including the plunger head, needle guard clips, finger grip, label, needle cap, plunger rod, plunger, body, and viewing window. It gives a detailed description of the parts that make up the syringe, which is essential for understanding its structure and function.*

FDA Label Image

Figure (Wezlana 06)

FDA Label Image

Figure (Wezlana 07)

FDA Label Image

Figure (Wezlana 08)

This text provides a simple and clear instruction to store a product in its original packaging in the refrigerator until it is ready to be used. This helps to maintain the product's freshness and quality.*

FDA Label Image

Figure (Wezlana 09)

FDA Label Image

Figure (Wezlana 10)

FDA Label Image

Figure (Wezlana 11)

FDA Label Image

Figure (Wezlana 12)

This text lists essential items for first aid: alcohol wipe, cotton ball or gauze pad, sharps disposal container, and adhesive bandage. These items are commonly used to disinfect wounds and apply dressings in case of injuries.*

FDA Label Image

Figure (Wezlana 13)

FDA Label Image

Figure (Wezlana 14)

FDA Label Image

Figure (Wezlana 15)

FDA Label Image

Figure (Wezlana 16)

FDA Label Image

Figure (Wezlana 17)

FDA Label Image

Figure (Wezlana 18)

FDA Label Image

Figure (Wezlana 19)

FDA Label Image

Figure (Wezlana 20)

FDA Label Image

Figure (Wezlana 21)

FDA Label Image

Figure (Wezlana 22)

FDA Label Image

Figure (Wezlana 23)

FDA Label Image

Figure (Wezlana 24)

FDA Label Image

Figure A (Wezlana 25)

This text appears to mention items that may be essential for a first aid kit or medical supply. It includes adhesive alcohol wipes, cotton balls or bandage gauze pads, FDA-cleared sharps disposal, syringe and attached needle, and a vial. These items are commonly used for wound care and medical procedures.*

FDA Label Image

Figure B (Wezlana 26)

FDA Label Image

Figure C (Wezlana 27)

FDA Label Image

Figure D (Wezlana 28)

FDA Label Image

Figure E (Wezlana 29)

FDA Label Image

Figure F (Wezlana 30)

FDA Label Image

Figure G (Wezlana 31)

FDA Label Image

Figure H (Wezlana 32)

FDA Label Image

Figure I (Wezlana 33)

FDA Label Image

Figure J (Wezlana 34)

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Syringe Carton)

This text provides information about a medication called WEZLANA™ (ustekinumab-auub). It advises not to shake or freeze the medication, keep it out of reach of children, and store it in the carton to protect it from light. The medication comes in single-dose prefilled syringes and should be stored refrigerated at 2° to 8°C (36° to 46°F). Unused portions should be discarded.*

FDA Label Image

Principal Display Panel (90 mg/mL Syringe Carton)

This text provides information about a medication called WEZLANA (ustekinumab-auub). It is a sterile solution with no preservatives for subcutaneous use only. It is advised to dispense the enclosed Medication Guide to each patient. The medication should be stored refrigerated at 2° to 8°C (36° to 46°F) and should not be shaken or frozen. It also highlights the importance of keeping it out of reach of children and storing it in the carton to protect it from light. The medication includes a single-dose prefilled syringe, and any unused portion should be discarded. Additional caution instructions and information for use are also mentioned.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Vial Carton)

This is a product label for a medication called WEZLANA™ (ekinumab-auub) in the strength of 45mg/0.5 mL supplied in single-dose vials for subcutaneous use. The medication should be stored refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. It is important to keep this medication out of reach of children and to dispense the enclosed Medication Guide to each patient. The solution is sterile, preservative-free, and should not be frozen or shaken.*

FDA Label Image

Principal Display Panel (130 mg/26 mL Vial Carton)

This is a description of the medication L ustekinumab-auub, which comes in a single-dose vial with a concentration of 130 mg/26 mL (5 mg/mL). It is for intravenous infusion only and must be stored refrigerated at 2°C to 8°C (36°F to 46°F). It is important to dispense the original carton to protect the medication from light. It is a sterile solution with no preservatives. Unused portions should be discarded.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Syringe Carton)

FDA Label Image

Principal Display Panel (90 mg/mL Syringe Carton)

This text appears to be a label for a medication called WEZLANA (ustekinumab-auub). It is a sterile solution for subcutaneous use only, stored refrigerated at 2° to 8°C. The medication guide should be provided to each patient. The solution should not be shaken or frozen. It should be kept out of reach of children and stored in its carton to protect it from light. The description advises to follow full prescribing information and instructions for use. The packaging includes a single-dose prefilled syringe, and any unused portion should be discarded.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Vial Carton)

Nuva is a medication called WEZLANA (ustekinumab-auub) provided in a 45 mg/0.5 mL injectable form for subcutaneous use only. This medication should be stored refrigerated at 2-8°C (36-46°F) in the original carton to protect it from light. Do not shake or freeze the medication. Each package includes a single-dose vial and a medication guide to be dispensed to each patient. The solution is sterile and has no preservatives. Unused portions should be discarded.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.